Prognostic factors in resected biliary tract cancers and the impact of cytokeratin 20 expression

dc.contributor.authorÇil, İbrahim
dc.contributor.authorOyman, Abdilkerim
dc.contributor.authorIşik, Selver
dc.contributor.authorAyhan, Murat
dc.contributor.authorÖkten, İlker Nihat
dc.contributor.authorYilmaz, Mesut
dc.contributor.authorÖzçelik, Melike
dc.date.accessioned2025-05-10T15:24:46Z
dc.date.issued2021
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractObjective: Surgical resection is the mainstay of treatment in biliary tract cancers. However, the prognostic factors after resection are not very well defined. Cytokeratins are a group of intermediate filaments present in epithelial tissues that play a crucial role in cell differentiation. Cytokeratin 20 (CK20) is frequently expressed in different types of cancers, but its effect on survival varies considerably. The current study aimed at assessing the prognostic factors as well as CK20 expression for survival outcomes, which has not yet been studied in this group of patients. Material and Methods: We performed a multicenter, retrospective analysis of patients diagnosed with biliary tract cancer and treated them with upfront surgery. In total, 81 patients from four oncology centers were involved in this study. We aimed to determine the impact of known clinicopathologic factors and CK20 expression on survival rates using Cox regression analysis. Results: Median follow-up was 21.6 months. Surgical margin status and lymph node metastases were independent factors for both disease-free (p=0.006 and p<0.001, respectively) and overall survival (OS) (p=0.004 and p<0.001, respectively), while perineural invasion (PNI) significantly influenced disease-free survival (DFS) (p=0.013). Patients with CK 20 expression had better DFS and OS; however, its prognostic effect was not demonstrated in multivariate analysis (p>0.05). Conclusion: Our study demonstrated that lymph node metastasis, positive surgical margins, and PNI were found to be potential prognostic factors for survival outcomes, whereas the CK20 expression was not precise enough to be considered as an independent factor affecting the prognosis. © 2021 by Turkish Society of Medical Oncology.
dc.identifier.doi10.37047/jos.2021-84414
dc.identifier.endpage132
dc.identifier.issn2651-4532
dc.identifier.issue3
dc.identifier.scopus2-s2.0-85120822818
dc.identifier.scopusqualityQ4
dc.identifier.startpage125
dc.identifier.trdizinid491711
dc.identifier.urihttps://doi.org/10.37047/jos.2021-84414
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/491711
dc.identifier.urihttps://hdl.handle.net/20.500.14730/6847
dc.identifier.volume7
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherTurkiye Klinikleri
dc.relation.ispartofJournal of Oncological Science
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_Scopus_20250302
dc.subjectBiliary tract cancer; Cytokeratin 20; Prognosis
dc.titlePrognostic factors in resected biliary tract cancers and the impact of cytokeratin 20 expression
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
6847.pdf
Boyut:
1.16 MB
Biçim:
Adobe Portable Document Format